Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema
suPAR (a) and IL-6 (b) plasma concentrations in normoxia and hypoxia, in HAPE-susceptible versus non-HAPE-susceptible persons. () denotes a difference in HAPE versus HAPE-susceptible subjects (). Boxplots represent median, interquartile range, and range. Horizontal scattering is applied to the individual data points in order to avoid superimposition. HAPE: high altitude pulmonary edema, suPAR: soluble urokinase-type plasminogen activator receptor, and IL-6: interleukin 6.